ENTITY
Ilyang Pharmaceutical Co.,

Ilyang Pharmaceutical Co., (007570 KS)

33
Analysis
Health CareSouth Korea
Il Yang Pharmaceutical Co., Ltd. manufactures a wide range of drugs acting on the digestive system, respiratory system, and circulatory system. The Company also produces antipyretic, analgesic, anti-inflammatory, and nutritional agents, tranquilizers, health food, insecticides, cosmetics, pharmaceutical raw materials, and therapeutic agents for liver and kidney disease.
more
Refresh
bullishKakaopay
24 Nov 2021 18:07

KOSPI200 Index Rebalance: Mostly Expected, Couple of Surprises

There are 6 adds and 7 deletes for the KOSPI200 at the Dec rebalance. Most of the changes were expected, but there are a couple of surprises. Kakao...

Logo
493 Views
Share
05 Nov 2021 08:21

KOSPI 200 Rebalancing Update After the Review Period Ended

This post is the latest update of the KOSPI 200 December rebalancing after the 6-month review period ended: rebalancing results, passive impact,...

Logo
196 Views
Share
02 Nov 2021 20:55

Ilyang Pharmaceutical (007570 KS): Leukemia Drug Commercialization Concerns Still Persist

This insight has analyzed commercialization concern over Ilyang's leukemia drug due to strong competition. Investors should avoid Ilyang shares.

Logo
99 Views
Share
01 Nov 2021 08:01

KOSPI200 Index Rebalance Preview:  Review Period Complete & Trades Performing Well

The review period for the KOSPI200 Dec rebalance is complete and we see 6 potential adds and 8 potential deletes. Most are high probability changes...

Logo
356 Views
Share
06 Oct 2021 12:57

KOSPI 200 December Rebalancing: 5 Adds/Deletes & Special Considerations

This post previews the KOSPI 200 December rebalancing: five likely adds and deletes through the regular screening and special considerations for...

Logo
405 Views
Share
x